233 related articles for article (PubMed ID: 28363694)
1. Cost-effectiveness of EOB-MRI for Hepatocellular Carcinoma in Japan.
Nishie A; Goshima S; Haradome H; Hatano E; Imai Y; Kudo M; Matsuda M; Motosugi U; Saitoh S; Yoshimitsu K; Crawford B; Kruger E; Ball G; Honda H
Clin Ther; 2017 Apr; 39(4):738-750.e4. PubMed ID: 28363694
[TBL] [Abstract][Full Text] [Related]
2. Health economic evaluation of Gd-EOB-DTPA MRI vs ECCM-MRI and multi-detector computed tomography in patients with suspected hepatocellular carcinoma in Thailand and South Korea.
Lee JM; Kim MJ; Phongkitkarun S; Sobhonslidsuk A; Holtorf AP; Rinde H; Bergmann K
J Med Econ; 2016 Aug; 19(8):759-68. PubMed ID: 27026278
[TBL] [Abstract][Full Text] [Related]
3. Performing Gadoxetic Acid-Enhanced MRI After CT for Guiding Curative Treatment of Early-Stage Hepatocellular Carcinoma: A Cost-Effectiveness Analysis.
Suh CH; Kim KW; Park SH; Kim SY; Woo DC; Shin S; Pyo J; Shinagare AB; Ramaiya NH; Lim YS
AJR Am J Roentgenol; 2018 Feb; 210(2):W63-W69. PubMed ID: 29091004
[TBL] [Abstract][Full Text] [Related]
4. Health economic assessment of Gd-EOB-DTPA MRI versus ECCM-MRI and multi-detector CT for diagnosis of hepatocellular carcinoma in China.
He X; Wu J; Holtorf AP; Rinde H; Xie S; Shen W; Hou J; Li X; Li Z; Lai J; Wang Y; Zhang L; Wang J; Li X; Ma K; Ye F; Ouyang H; Zhao H
PLoS One; 2018; 13(1):e0191095. PubMed ID: 29324837
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma detection in liver cirrhosis: diagnostic performance of contrast-enhanced CT vs. MRI with extracellular contrast vs. gadoxetic acid.
Semaan S; Vietti Violi N; Lewis S; Chatterji M; Song C; Besa C; Babb JS; Fiel MI; Schwartz M; Thung S; Sirlin CB; Taouli B
Eur Radiol; 2020 Feb; 30(2):1020-1030. PubMed ID: 31673837
[TBL] [Abstract][Full Text] [Related]
6. Cost evaluation of gadoxetic acid-enhanced magnetic resonance imaging in the diagnosis of colorectal-cancer metastasis in the liver: Results from the VALUE Trial.
Zech CJ; Justo N; Lang A; Ba-Ssalamah A; Kim MJ; Rinde H; Jonas E
Eur Radiol; 2016 Nov; 26(11):4121-4130. PubMed ID: 26905871
[TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced computed tomography plus gadolinium-ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging for gross classification of hepatocellular carcinoma.
Chen C; Zhao H; Fu X; Huang L; Tang M; Yan X; Sun S; Jia W; Mao L; Shi J; Chen J; He J; Zhu J; Qiu Y
Oncotarget; 2017 May; 8(18):29741-29750. PubMed ID: 28392502
[TBL] [Abstract][Full Text] [Related]
8. Intra-individual comparison of hepatocellular carcinoma imaging features on contrast-enhanced computed tomography, gadopentetate dimeglumine-enhanced MRI, and gadoxetic acid-enhanced MRI.
Kim YN; Song JS; Moon WS; Hwang HP; Kim YK
Acta Radiol; 2018 Jun; 59(6):639-648. PubMed ID: 28825310
[TBL] [Abstract][Full Text] [Related]
9. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
[TBL] [Abstract][Full Text] [Related]
10. Comparison of international guidelines for diagnosis of hepatocellular carcinoma and implications for transplant allocation in liver transplantation candidates with gadoxetic acid enhanced liver MRI versus contrast enhanced CT: a prospective study with liver explant histopathological correlation.
Odedra D; Jandaghi AB; Bhayana R; Elbanna KY; Espin-Garcia O; Fischer SE; Ghanekar A; Sapisochin G; Jhaveri KS
Cancer Imaging; 2022 Oct; 22(1):55. PubMed ID: 36195953
[TBL] [Abstract][Full Text] [Related]
11. Gadoxetic acid disodium-enhanced magnetic resonance imaging outperformed multidetector computed tomography in diagnosing small hepatocellular carcinoma: A meta-analysis.
Liu X; Jiang H; Chen J; Zhou Y; Huang Z; Song B
Liver Transpl; 2017 Dec; 23(12):1505-1518. PubMed ID: 28886231
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic performance of contrast-enhanced multidetector computed tomography and gadoxetic acid disodium-enhanced magnetic resonance imaging in detecting hepatocellular carcinoma: direct comparison and a meta-analysis.
Guo J; Seo Y; Ren S; Hong S; Lee D; Kim S; Jiang Y
Abdom Radiol (NY); 2016 Oct; 41(10):1960-72. PubMed ID: 27318936
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the health economic impact of initial diagnostic modality selection in patients suspected of having HCC in China and the USA.
Blankenburg M; Elhamamy M; Zhang D; Corbin A; Jin G; Harris J; Knobloch G
J Med Econ; 2022; 25(1):1015-1029. PubMed ID: 35930705
[TBL] [Abstract][Full Text] [Related]
14. Comparison of CT and gadoxetic acid-enhanced MRI with liver imaging reporting and data system to assess liver tumors before resection.
Chen MF; Ho MC; Kao JH; Hwang RM; Deng SB; Yen KC; Liang PC; Wu CH
J Formos Med Assoc; 2024 Mar; 123(3):318-324. PubMed ID: 38044205
[TBL] [Abstract][Full Text] [Related]
15. Is 3-Tesla Gd-EOB-DTPA-enhanced MRI with diffusion-weighted imaging superior to 64-slice contrast-enhanced CT for the diagnosis of hepatocellular carcinoma?
Maiwald B; Lobsien D; Kahn T; Stumpp P
PLoS One; 2014; 9(11):e111935. PubMed ID: 25375778
[TBL] [Abstract][Full Text] [Related]
16. Detection of hepatocellular carcinoma by Gd-EOB-DTPA-enhanced liver MRI: comparison with triple phase 64 detector row helical CT.
Akai H; Kiryu S; Matsuda I; Satou J; Takao H; Tajima T; Watanabe Y; Imamura H; Kokudo N; Akahane M; Ohtomo K
Eur J Radiol; 2011 Nov; 80(2):310-5. PubMed ID: 20732773
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of health economic impact of initial diagnostic modality selection for colorectal cancer liver metastases in suspected patients in China, Japan and the USA.
Blankenburg M; Elhamamy M; Zhang D; Fujikawa N; Corbin A; Jin G; Harris J; Knobloch G
J Med Econ; 2023; 26(1):219-232. PubMed ID: 36705988
[TBL] [Abstract][Full Text] [Related]
18. A cost-effectiveness analysis of the diagnostic strategies for differentiating focal nodular hyperplasia from hepatocellular adenoma.
Suh CH; Kim KW; Park SH; Shin S; Ahn J; Pyo J; Shinagare AB; Krajewski KM; Ramaiya NH
Eur Radiol; 2018 Jan; 28(1):214-225. PubMed ID: 28726119
[TBL] [Abstract][Full Text] [Related]
19. Comparison of gadoxetic acid-enhanced dynamic MR imaging and contrast-enhanced computed tomography for preoperative evaluation of colorectal liver metastases.
Asato N; Tsurusaki M; Sofue K; Hieda Y; Katsube T; Kitajima K; Murakami T
Jpn J Radiol; 2017 Apr; 35(4):197-205. PubMed ID: 28251499
[TBL] [Abstract][Full Text] [Related]
20. Gadoxetic acid-enhanced MRI for the characterization of hepatocellular carcinoma: A systematic review and meta-analysis.
Duncan JK; Ma N; Vreugdenburg TD; Cameron AL; Maddern G
J Magn Reson Imaging; 2017 Jan; 45(1):281-290. PubMed ID: 27299482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
